XCNQ
PMED
Market cap3mUSD
, Last price
CAD
Name
Predictmedix Inc
Chart & performance
P/E
—
P/S
—
EPS
—
Vol. 1Y
—
Shs. 5Y
13.77%
Rev. 5Y
%
Div Yld LY
—
Div Yld TTM
—
Revenues
0
Net income
-1m
L-0.86%
CFO
-1m
L+2,966.09%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Predictmedix Inc. is an artificial intelligence firm dedicated to creating advanced AI-driven solutions for general workplace well-being and the broader healthcare sector. Its operations are structured around two core divisions: Workplace Health and Safety, and Healthcare services. The company provides symptom screening systems designed to identify individuals with a higher probability of carrying infectious diseases, guiding them towards definitive diagnostic tests such as rapid COVID assessments. Additionally, Predictmedix develops impairment detection scanners, specialized mental health screening stations, and the Mobile Wellbeing platform, which facilitates remote patient monitoring through telemedicine. The company, formerly known as Cultivar Holdings Inc., rebranded to Predictmedix Inc. in April 2020 and is headquartered in Toronto, Canada.
Key people
Sheldon Kales
President, Chief Executive Officer, Director · since 2019
Chief Financial Officer, Corporate Secretary · since 2019
Rahul Kushwah
Chief Operating Officer, Director · since 2019
Legal address
855 WEST GEORGIA STREET
SUITE 800
VANCOUVER, BC V6C 3H1
CA
SUITE 800
VANCOUVER, BC V6C 3H1
CA
Headquarters
77 KING STREET WEST
SUITE 3000
TORONTO, ON M5K 1G8
CA
SUITE 3000
TORONTO, ON M5K 1G8
CA
Previous name
PREDICTMEDIX INC.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2026‑01 | 2025‑01 | 2024‑01 | 2023‑01 | 2022‑01 | 2021‑01 | 2020‑01 | 2019‑01 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||